Search Result "antiplasmin-cleaving enzyme"
α2-Antiplasmin: Potential Therapeutic Roles in Fibrin Survival and Removal
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2 Issue: 4 Year: 2004 Page: 303-310
Author(s): Kyung N. Lee, Kenneth W. Jackson, Victoria J. Christiansen, Keun H. Chung, Patrick A. McKee
Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 5 Issue: 2 Year: 2008 Page: 212-224
Author(s): Natalia N. Nalivaeva, Lilia R. Fisk, Nikolai D. Belyaev, Anthony J. Turner
α2-Antiplasmin on Cardiovascular Diseases
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 7 Year: 2006 Page: 841-847
Author(s): Hiroyuki Matsuno
Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Journal: Protein & Peptide Letters
Volume: 21 Issue: 12 Year: 2014 Page: 1209-1229
Author(s): Mateja Mancek-Keber
Prolyl Peptidases Related to Dipeptidyl Peptidase IV: Potential of Specific Inhibitors in Drug Discovery.
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 621-635
Author(s): Pieter Van der Veken, Achiel Haemers, Koen Augustyns
Proteases of Porphyromonas gingivalis as Important Virulence Factors in Periodontal Disease and Potential Targets for Plant-Derived Compounds: A Review Article
Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 322-331
Author(s): Daniel Grenier, Vu Dang La
Dipeptidyl-Peptidase IV (DPP IV/CD26)-Activated Prodrugs: A Successful Strategy for Improving Water Solubility and Oral Bioavailability
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 8 Year: 2015 Page: 1041-1054
Author(s): Sonsoles Velazquez,Sonia de Castro,Alberto Diez-Torrubia,Jan Balzarini,MarÃa-Jose Camarasa
Role of Cellular Elements in Thrombus Formation and Dissolution
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6 Issue: 3 Year: 2008 Page: 224-228
Author(s): N. Wohner
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis
Journal: Current Drug Targets
Volume: 20 Issue: 16 Year: 2019 Page: 1695-1701
Author(s): Tetsumei Urano,Yuko Suzuki,Takayuki Iwaki,Hideto Sano,Naoki Honkura,Francis J. Castellino
A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 3 Year: 2009 Page: 276-294
Author(s): S. Brogger Christensen, Dorthe Mondrup Skytte, Samuel R. Denmeade, Craig Dionne, Jesper Vuust Moller, Poul Nissen, John T. Isaacs